Chimeric Therapeutics Ltd. ( (AU:CHM) ) just unveiled an announcement.
Chimeric Therapeutics Ltd. has announced a non-renounceable pro rata entitlement offer to raise approximately $3.2 million through the issuance of new shares and options. The offer includes 2 new shares for every 5 existing shares and 1 new option for each new share issued. Additionally, up to 25 million adviser options will be issued to PAC Partners Securities Pty Ltd and Taylor Collison Limited as joint lead managers. This move is aimed at strengthening the company’s financial position and is considered speculative, indicating potential risks for investors.
More about Chimeric Therapeutics Ltd.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$7.98M
See more data about CHM stock on TipRanks’ Stock Analysis page.